As of September 2024, Tanvex BioPharma has a market cap of $295.73M. This makes Tanvex BioPharma the world's 14806th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $265.57M | -2.61% |
2023 | $272.69M | 85.47% |
2022 | $147.03M | -39.59% |
2021 | $243.37M | 55.35% |
2020 | $156.66M | -16.42% |
2019 | $187.45M | -27.93% |
2018 | $260.09M | -16.68% |
2017 | $312.17M | -51.13% |
2016 | $638.78M | -32.12% |
2015 | $941.02M | - |